• ICAPE reaffirmed its September 30, 2026 guidance for annual revenue growth of at least 18%, versus 12% initially.
• Organic growth remains targeted at around 18%, assuming no further currency deterioration; the EBIT margin target remains around 6%.
• Acquisition-related revenue is projected at approximately EUR 5 million, versus EUR 28 million previously, following an uncompleted transaction in July.
• Nine-month revenue rose 20.5% to EUR 182 million, driven mainly by price increases amid AI-related supply pressures.
• Order backlog reached USD 152.9 million on October 31, up 138% year over year, supporting the outlook.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Icape Holding SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20261103846126) on November 03, 2026, and is solely responsible for the information contained therein.